PAIN Reports (Dec 2024)

Validation of a holistic composite outcome measure for the evaluation of chronic pain interventions

  • Rod S. Taylor,
  • Quinton Neville,
  • Christopher M. Mullin,
  • Nagy A. Mekhail,
  • Jan W. Kallewaard,
  • Salim Hayek,
  • Jason E. Pope,
  • Corey W. Hunter,
  • Shrif J. Costandi,
  • Leonardo Kapural,
  • Christopher A. Gilmore,
  • Erika A. Petersen,
  • Kiran V. Patel,
  • Sam Eldabe,
  • Robert M. Levy,
  • Christopher Gilligan,
  • Shravani Durbhakula,
  • Alaa Abd-Elsayed,
  • Marshall Bedder,
  • Patrick Buchanan,
  • Erin Hanson,
  • Angela Leitner,
  • Nicole Soliday,
  • Rui V. Duarte,
  • Daniel J. Clauw,
  • Turo J. Nurmikko

DOI
https://doi.org/10.1097/PR9.0000000000001202
Journal volume & issue
Vol. 9, no. 6
p. e1202

Abstract

Read online

Abstract. Introduction:. Chronic pain is a personal experience influenced by multiple biopsychosocial factors. Using a pain intensity measure alone to assess the effectiveness of a chronic pain intervention fails to fully evaluate its impact on the multifaceted chronic pain experience. The holistic minimal clinically important difference (MCID) is a composite outcome developed to provide a comprehensive assessment of chronic pain in response to intervention, across 5 outcome domains: pain intensity, health-related quality of life, sleep quality, physical, and emotional function. To focus on domains where the individual need is greatest, the holistic MCID reflects the cumulative MCID averaged over only the domains where subjects were impaired preintervention. Objectives:. To assess the internal and construct validity of the Holistic MCID score to inform its future use as an evidence-based tool. Methods:. This validation study was undertaken using data from the EVOKE trial with 111 patients up to 24-month follow-up. Internal consistency of the holistic MCID was assessed using Cronbach alpha statistic and dimensional exploration using principal component analysis. Results:. The holistic MCID measure demonstrated strong internal consistency with Cronbach alpha >0.7 at all follow-ups. Principal component analysis showed one overarching holistic dimension to be present in the composite. Construct validity was demonstrated by an increase in the holistic MCID score being associated with both increased Patients' Global Impression of Change, EuroQol visual analogue scale score, and each of the outcome domains in a “leave-one-out” analysis (all P < 0.001). Conclusion:. The holistic MCID provides a valid measure for the comprehensive, personalized assessment of response after a chronic pain intervention. The validity of the holistic MCID requires further confirmation in other chronic pain populations and with different interventions.